Clinical Trial 49146

Miami, FL 33155


Phase Ib, Randomized, Double-Blind, Parallel Group, Placebo-
Controlled Study of the Clinical Effect, Safety and Tolerability of a Single Intravenous

Infusion of GSK1070806 in Moderate to Severe Atopic Dermatitis Patients.

Qualified Participants Must:

• Moderate to severe atopic dermatitis (confirmed by a dermatologist) according to the Hannifin and Rajka criteria or Eichenfield revised criteria
• Onset of AtD symptoms occurring at least 6 months prior to Screening, with stable disease for at least 1 month prior to Screening

Qualified Participants May Receive:

up to $2500

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.